Both in Pharmaceuticals
ARS Pharmaceuticals vs Turn Therapeutics
Over the past year SPRY returned −60.8% and TTRX returned +136.0%; their daily moves had a correlation of 0.09.
SPRY −60.8% TTRX +136.0%Growth of $1, one year, split-adjusted
| Metric | SPRY | TTRX |
|---|---|---|
| Price | $3.38 | $10.43 |
| Market cap | $336.1M | $316.7M |
| Today | −7.65% | −2.71% |
| 1 month | −18.0% | −21.6% |
| 6 months | −60.5% | +174.5% |
| Year to date | −71.0% | +164.7% |
| 1 year | −62.4% | +98.7% |
| Revenue growth (YoY) | +114.2% | — |
| Gross margin | 61.8% | — |
| Net margin | −185.2% | — |
| P/E (TTM) | — | — |
| Price / sales | 2.9× | — |
| Net cash | -$27.8M | $4.2M |
| Dividend yield | — | — |
| Volatility (60d) | 71.5% | 91.6% |
| Short % of float | 40.5% | 3.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).